Age cutoff in lymphoma diagnosis

Por Ok, Chi Y., Young, Ken H.
Publicado no Aging (Albany NY) (2015)

Checkpoint inhibitors in hematological malignancies

Por Ok, Chi Young, Young, Ken H.
Publicado no J Hematol Oncol (2017)

Targeting the Programmed Death-1 Pathway in Lymphoid Neoplasms

Por Ok, Chi Young, Young, Ken H.
Publicado no Cancer Treat Rev (2017)

The TP53 tumor suppressor and autophagy in malignant lymphoma

Por Xu-Monette, Zijun Y., Young, Ken H.
Publicado em 2012

Epstein–Barr virus-positive T/NK-cell lymphoproliferative disorders

Por Cai, Qingqing, Chen, Kailin, Young, Ken H
Publicado no Exp Mol Med (2015)

The PTEN tumor suppressor gene and its role in lymphoma pathogenesis

Por Wang, Xiaoxiao, Huang, Huiqiang, Young, Ken H.
Publicado no Aging (Albany NY) (2015)

Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid Malignancies

Por Sun, Ruifang, Wang, Jinfen, Young, Ken H.
Publicado no Crit Rev Oncog (2017)

Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment()

Por Cai, Qingqing, Fang, Yu, Young, Ken H.
Publicado no Transl Oncol (2019)

EBV-driven B-cell lymphoproliferative disorders: from biology, classification and differential diagnosis to clinical management

Por Ok, Chi Young, Li, Ling, Young, Ken H
Publicado no Exp Mol Med (2015)

Signaling Pathway and Dysregulation of PD1 and its Ligands in Lymphoid Malignancies

Por Xia, Yi, Medeiros, L. Jeffrey, Young, Ken H.
Publicado no Biochim Biophys Acta (2015)

Cancer Immunotherapy in Diffuse Large B-Cell Lymphoma

Por Zhang, Jun, Medeiros, L. Jeffrey, Young, Ken H.
Publicado no Front Oncol (2018)

Cross-talk between Myc and p53 in B-cell lymphomas

Por Yu, Li, Yu, Tian-Tian, Young, Ken H.
Publicado no Chronic Dis Transl Med (2019)

PD-1 expression and clinical PD-1 blockade in B-cell lymphomas

Por Xu-Monette, Zijun Y., Zhou, Jianfeng, Young, Ken H.
Publicado no Blood (2018)

Critically dysregulated signaling pathways and clinical utility of the pathway biomarkers in lymphoid malignancies

Por Sun, Rui-Fang, Yu, Qian-Qian, Young, Ken H.
Publicado no Chronic Dis Transl Med (2018)

Epstein-Barr Virus-Positive Natural Killer/T-Cell Lymphoma

Por Cai, Qingqing, Cai, Jun, Fang, Yu, Young, Ken H.
Publicado no Front Oncol (2019)

Fulminant EBV-driven CD8 T-cell Lymphoproliferative Disorder Following Primary Acute EBV Infection: A Unique Spectrum of T-Cell Malignancy

Por Young, Ken H, Zhang, Dahua, Malik, Jeffery T, Williams, Eliot C
Publicado em 2008

MYC-driven aggressive B-cell lymphomas: biology, entity, differential diagnosis and clinical management

Por Cai, Qingqing, Medeiros, L. Jeffrey, Xu, Xiaolu, Young, Ken H.
Publicado no Oncotarget (2015)

NF-κB Signaling Pathway and its Potential as a Target for Therapy in Lymphoid Neoplasms

Por Yu, Li, Li, Ling, Medeiros, L. Jeffrey, Young, Ken H.
Publicado no Blood Rev (2016)

Prevalence of bortezomib-resistant constitutive NF-kappaB activity in mantle cell lymphoma

Por Yang, David T, Young, Ken H, Kahl, Brad S, Markovina, Stephanie, Miyamoto, Shigeki
Publicado em 2008

Detection of Human Herpesvirus DNA in Kikuchi-Fujimoto Disease and Reactive Lymphoid Hyperplasia

Por Hudnall, S David, Chen, Tiansheng, Amr, Samir, Young, Ken H, Henry, Kristin
Publicado em 2008